CD274 and neoplasm: Tested markers such as PD-L1 expression, tumor mutation burden, somatic mutations and copy number alterations, gene expression profiles and tumor microenvironment factors have in common that implication into clinical practice is challenging due to several challenges like variable predictive values, different cut-offs and assays being used and the requirement of tumor tissue in many cases.